{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:12:17Z","timestamp":1759839137303,"version":"build-2065373602"},"reference-count":21,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2013,12,20]]},"published-print":{"date-parts":[[2014,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We evaluated the efficacy and safety of an early invasive strategy post-fibrinolysis in relation to glycoprotein (GP) IIb\/IIIa inhibitor use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) randomised 1059 ST elevation myocardial infarction patients to an early invasive strategy or standard therapy post-fibrinolysis. The primary end point was the composite of death, reinfarction, recurrent ischaemia, new or worsening heart failure, or cardiogenic shock at 30\u2005days. In this pre-specified analysis, we examined efficacy and safety outcomes of an early invasive strategy after stratification by GPIIb\/IIIa inhibitor use, which was permitted during percutaneous coronary intervention (PCI) at the discretion of the treating physician.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 695 patients (65.6%) received GPIIb\/IIIa inhibitors. There was significant heterogeneity (p&lt;0.001) in the efficacy of an early invasive strategy compared to standard therapy, between the strata with GPIIb\/IIIa inhibitor use (primary end point 9.6% vs 22.3% respectively, p&lt;0.001) and without GPIIb\/IIIa inhibitor use (primary end point 14.8% vs 10.4% respectively, p=0.21). Patients who received GPIIb\/IIIa inhibitors had lower Global Registry of Acute Coronary Events (GRACE) risk scores compared to those without GPIIb\/IIIa inhibitor use (median 121 vs 130, p&lt;0.001). After adjusting for the interaction between GRACE risk score and treatment assignment, the heterogeneity in the efficacy of an early invasive strategy with respect to GPIIb\/IIIa inhibitor use was no longer significant (p interaction=0.08).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The apparent difference in the efficacy of an early invasive strategy between GPIIb\/IIIa inhibitor strata likely reflects an association between GPIIb\/IIIa inhibitor use and baseline risk. GPIIb\/IIIa inhibitor use during PCI at the discretion of the treating physician does not appear to modulate the efficacy of an early invasive strategy post-fibrinolysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trial Registration:<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00164190\" ext-link-type=\"uri\">http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00164190<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00164190\">NCT00164190<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2013-305231","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:48:02Z","timestamp":1390351682000},"page":"873-880","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb\/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial"],"prefix":"10.1136","volume":"100","clinical-trial-number":[{"clinical-trial-number":"nct00164190","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Juan J","family":"Russo","sequence":"first","affiliation":[{"name":"Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun G","family":"Goodman","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"},{"name":"Canadian Heart Research Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren J","family":"Cantor","sequence":"additional","affiliation":[{"name":"Southlake Regional Health Centre, Newmarket, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fitchett","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Heffernan","sequence":"additional","affiliation":[{"name":"Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjug","family":"Borgundvaag","sequence":"additional","affiliation":[{"name":"Schwartz\/Reisman Emergency Centre, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ducas","sequence":"additional","affiliation":[{"name":"St. Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A","family":"Cohen","sequence":"additional","affiliation":[{"name":"Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"D\u017eav\u00edk","sequence":"additional","affiliation":[{"name":"University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamir R","family":"Mehta","sequence":"additional","affiliation":[{"name":"Population Health Research Institute, Hamilton, Ontario and Hamilton General Hospital, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E","family":"Buller","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T","family":"Yan","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the TRANSFER-AMI investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"2025100704284209000_100.11.873.1","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1993"},{"key":"2025100704284209000_100.11.873.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.6.1710"},{"key":"2025100704284209000_100.11.873.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00444-1"},{"key":"2025100704284209000_100.11.873.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.5.1457"},{"key":"2025100704284209000_100.11.873.5","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.045278"},{"key":"2025100704284209000_100.11.873.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808276"},{"key":"2025100704284209000_100.11.873.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60268-8"},{"key":"2025100704284209000_100.11.873.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.08.025"},{"key":"2025100704284209000_100.11.873.9","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.77.1.142"},{"key":"2025100704284209000_100.11.873.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.23.2690"},{"key":"2025100704284209000_100.11.873.11","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.68.10.374"},{"key":"2025100704284209000_100.11.873.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00172-7"},{"key":"2025100704284209000_100.11.873.13","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-52"},{"key":"2025100704284209000_100.11.873.14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.19.2345"},{"key":"2025100704284209000_100.11.873.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr008"},{"key":"2025100704284209000_100.11.873.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.109.920868"},{"key":"2025100704284209000_100.11.873.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.06.050"},{"key":"2025100704284209000_100.11.873.18","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-010-0461-9"},{"key":"2025100704284209000_100.11.873.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68147-6"},{"key":"2025100704284209000_100.11.873.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706816"},{"key":"2025100704284209000_100.11.873.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq204"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2013-305231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:28:51Z","timestamp":1759836531000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2013-305231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,5,8]]},"published-print":{"date-parts":[[2014,6,1]]}},"alternative-id":["10.1136\/heartjnl-2013-305231"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2013-305231","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}